Plasmonica Bio was founded to radically improve the probability of success for neurotherapeutics in clinical trials. In pioneering electro-plasmonic sensing, the Plasmonica team is able to record large populations of electrically active cells in vitro with subcellular resolution and high-throughput capacity. By introducing groundbreaking new assays based on electro-plasmonics, Plasmonica produces the most advanced functional electrophysiology screening data in the world.
We soon discovered that our technology has game changing applications for other fields of biology. In microbiology, Plasmonica has developed high-throughput assays that quantify microbial motility as a rapid, functional readout of antimicrobial response. Because motility disruptions often precede changes in growth or viability, this approach enables earlier and more sensitive detection of drug effects. By measuring behavioral dynamics across large populations in real time, Plasmonica provides faster, more predictive insight into antimicrobial efficacy and resistance.